Skip to content

Advances in Motion provides health care professionals with information about the latest breakthroughs, research and clinical advances from Massachusetts General Hospital.

Featured In Research and Innovation

Five early immune response markers, considered together, correctly classified plasma samples as belonging to survivors or non-survivors of severe COVID-19.

Featured In Cardiovascular

Massachusetts General Hospital is one of five donation after circulatory death (DCD) heart transplant centers in the U.S., investigating DCD donor hearts for transplantation.

Featured In Pulmonary and Critical Care

In this Q&A, Leo C. Ginns, MD, and George A. Alba, MD, physicians in the Division of Pulmonary Care and Critical Care Medicine at Massachusetts General Hospital, describe the development and purpose of the Coronavirus Recovery (CORE) Clinic, of which they are director and associate director (respectively).

Featured In OB/GYN

High-dose nitric oxide gas rapidly improved shortness of breath in six pregnant patients who had severe or critical COVID-19, and in five cases viral infection resolved within 28 days.

Featured In Geriatrics and Palliative Care

Christine Seel Ritchie, MD, MSPH, of the Mongan Institute and Division of Palliative Care and Geriatric Medicine at Massachusetts General Hospital, and colleagues have four pointers for clinicians in safety net settings who want to optimize care of adults with geriatric conditions.

The Latest Neuroscience Advances

In this Q&A, Daphne J. Holt, MD, PhD, teaches skills for dealing with the overwhelming stress on health care workers during the pandemic and discusses how learning resiliency through online training can help them manage their mental health during this stressful time.

Massachusetts General Hospital researchers have identified and validated a distinctive pattern of abnormal brain connections on functional MRI that discriminates between patients with and without migraine.

Contributing Physicians

Psychiatrist-In-Chief; Director, Division of Clinical Research of the MGH Research Institute, Executive Director, Clinical Trials Network and Institute (CTNI), Massachusetts General Hospital, Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School

Chief of Psychology, Massachusetts General Hospital, Director, OCD and Related Disorders Program, MGH, Professor, Harvard Medical School

Advances Specialties

Cardiovascular

Current guideline-based strategies for estimating a patient's risk of coronary artery disease do not account fully for inherited susceptibility.

Geriatrics and Palliative Care

Between 2014 and 2018, 43 billion doses of potentially inappropriate medications were dispensed to adults over 65, with spending of $25.2 billion.

Radiology

Massachusetts General Hospital researchers have identified and validated a distinctive pattern of abnormal brain connections on functional MRI that discriminates between patients with and without migraine.

Education & Training Opportunities

October 14-16, 2020

This live-streamed program provides a comprehensive review of state-of-the-art practices to diagnose and treat patients with cardiovascular conditions. Led by the leading clinical faculty of Harvard Medical School and the Corrigan Minehan Heart Center at Massachusetts General Hospital, Update for Clinical Cardiology ensures attendees are informed about recent advances in clinical cardiology and the best ways to incorporate them into daily practice to optimize patient outcomes.

July 21, 2020 - August 12, 2020

The symposia, organized by the Department of Neurology at Massachusetts General Hospital, will cover a broad range of studies at the molecular, cellular, circuit/systems and behavioral levels, with the hope of uniting expertise under the general neuroscience umbrella.

Clinical Trials

In Neuroscience

If you are a mother who has experienced an episode of postpartum psychosis within the past ten years, you could help us to better understand this serious disorder.

In Cardiovascular

As part of the study, participants will be asked to eat up to 2 meals and take a commonly used medication that also influences metabolism.